Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups

Documenti analoghi

• Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation
  di: Dufour, Carlo, et al.
  Pubblicazione: (2014)
• Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis
  di: Bacigalupo, Andrea, et al.
  Pubblicazione: (2015)
• Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party
  di: Marsh, JCW, et al.
  Pubblicazione: (2010)
• Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen
  di: Maury, Sébastien, et al.
  Pubblicazione: (2009)
• Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia
  di: Schrezenmeier, Hubert, et al.
  Pubblicazione: (2007)